David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Wave Life Sciences
WVE
$1.03B
| $5.4M | ﹤0.01% |
1,101,650
-153,910
| -12% | -$933K |
|
1902
PUT
AngloGold Ashanti
AU
$59.7B
| $5.4M | ﹤0.01% |
337,500
+235,000
| +229% | +$4.07M |
|
1903
PUT
Expeditors International
EXPD
$24.7B
| $5.4M | ﹤0.01% |
+45,300
| New | +$5.67M |
|
1904
CALL
West Pharmaceutical
WST
$24.6B
| $5.39M | ﹤0.01% |
+12,700
| New | +$5.35M |
|
|
VISN
1905
Vistance Networks Inc
VISN
$2.55B
| $5.39M | ﹤0.01% |
396,523
+382,684
| +2,765% | +$6.58M |
|
|
FRGE
1906
DELISTED
Forge Global Holdings
FRGE
| $5.36M | ﹤0.01% |
36,117
+12,799
| +55% | +$1.88M |
|
|
MBTC
1907
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
| $5.36M | ﹤0.01% |
+536,638
| New | +$5.32M |
|
1908
CALL
Prudential Financial
PRU
$41.5B
| $5.36M | ﹤0.01% |
50,900
-34,700
| -41% | -$3.58M |
|
1909
CALL
Constellation Brands
STZ
$23B
| $5.35M | ﹤0.01% |
25,400
+5,400
| +27% | +$1.18M |
|
1910
PUT
AstraZeneca
AZN
$258B
| $5.35M | ﹤0.01% |
44,520
| – | – |
|
|
VMRK
1911
PUT
Vivmark Residential
VMRK
$26.7B
| $5.33M | ﹤0.01% |
+65,900
| New | +$5.44M |
|
1912
PUT
Penumbra
PEN
$12.7B
| $5.33M | ﹤0.01% |
20,000
| – | – |
|
1913
Masco
MAS
$14.5B
| $5.32M | ﹤0.01% |
95,772
-239,750
| -71% | -$14.2M |
|
|
ZEN
1914
DELISTED
ZENDESK INC
ZEN
| $5.31M | ﹤0.01% |
45,639
-17,032
| -27% | -$2.2M |
|
1915
Anterix
ATEX
$1.85B
| $5.31M | ﹤0.01% |
87,435
+699
| +0.8% | +$41K |
|
1916
CALL
Monolithic Power Systems
MPWR
$64.1B
| $5.28M | ﹤0.01% |
+10,900
| New | +$4.96M |
|
1917
Kennametal
KMT
$2.29B
| $5.28M | ﹤0.01% |
154,272
+66,785
| +76% | +$2.4M |
|
|
CFIV
1918
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $5.28M | ﹤0.01% |
542,740
+260,097
| +92% | +$2.53M |
|
1919
Glacier Bancorp
GBCI
$6.14B
| $5.27M | ﹤0.01% |
95,177
+76,713
| +415% | +$4.04M |
|
1920
CALL
3M
MMM
$92.8B
| $5.26M | ﹤0.01% |
35,880
-50,830
| -59% | -$8.24M |
|
1921
Kimco Realty
KIM
$16.1B
| $5.25M | ﹤0.01% |
253,004
-2,058,280
| -89% | -$44M |
|
1922
Immersion
IMMR
$255M
| $5.25M | ﹤0.01% |
766,947
+386,881
| +102% | +$2.89M |
|
1923
Upbound Group
UPBD
$1.13B
| $5.24M | ﹤0.01% |
93,167
-120,873
| -56% | -$7.12M |
|
|
DHBC
1924
DELISTED
DHB Capital Corp. Class A common stock
DHBC
| $5.21M | ﹤0.01% |
537,286
+403,953
| +303% | +$3.91M |
|
|
AMWD
1925
DELISTED
American Woodmark
AMWD
| $5.21M | ﹤0.01% |
79,699
+18,046
| +29% | +$1.33M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.